Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction

Jasper W.L. Hartog, Ruud M. Van De Wal, Casper G. Schalkwijk, Toshio Miyata, Wybren Jaarsma, H. W.Thijs Plokker, Leen M. Van Wijk, Andries J. Smit, Dirk J. Van Veldhuisen, Adriaan A. Voors

研究成果: Article査読

18 被引用数 (Scopus)

抄録

AimsTo investigate the relationship between advanced glycation end-products (AGEs) and diastolic function and the response to blood pressure treatment in patients with hypertension and diastolic dysfunction.Methods and resultsData were analysed from 97 patients (aged 65 ± 10 years, 36 male) who were randomly assigned to 6 months open-label treatment with either eprosartan on top of other anti-hypertensive drugs (n = 47) or other anti-hypertensive drugs alone (n = 50). Tissue AGE accumulation was measured using a validated skin-autofluorescence (skin-AF) reader (n = 26). Plasma N ε- (carboxymethyl)lysine (CML), N ε-(carboxyethyl)lysine (CEL), and pentosidine were measured by LC-MS/MS and HPLC. Diastolic function was assessed using echocardiography. Blood pressure was reduced from 157/91 to 145/84 mmHg (P < 0.001) in the eprosartan group and from 158/91 to 141/83 mmHg (P < 0.001) in the control group. No effect of eprosartan was found on AGE levels. In patients with baseline skin-AF < median, E/A ratio (P = 0.04) and the mean peak early-diastolic filling velocity (E′) improved (P = 0.001). In contrast, in patients with skin-AF levels > median, E/A ratio (P = 0.84) and mean E′ (P = 0.32) remained unchanged.ConclusionAlthough eprosartan did not decrease levels of AGEs, patients with lower skin-AF at baseline showed a larger improvement in diastolic function in response to either anti-hypertensive treatment compared with patients with higher skin-AF.

本文言語English
ページ(範囲)397-403
ページ数7
ジャーナルEuropean Journal of Heart Failure
12
4
DOI
出版ステータスPublished - 2010 4

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

フィンガープリント 「Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル